L Livi

Summary

Country: Italy

Publications

  1. ncbi Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients
    L Livi
    Department of Radiotherapy, Florence University, Florence, Italy
    Eur J Surg Oncol 31:9-12. 2005
  2. ncbi Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery
    L Livi
    Radiotherapy Department, Florence University, Florence, Italy
    Clin Oncol (R Coll Radiol) 19:120-4. 2007
  3. ncbi Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines
    L Livi
    Department of Radiation Oncology, University of Florence, Florence, Italy
    J Chemother 23:158-62. 2011
  4. ncbi Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy
    L Livi
    Department of Radiotherapy Oncology, Viale Morgagni no 85, Florence University, 50134, Florence, Italy
    Eur J Surg Oncol 33:977-81. 2007
  5. ncbi Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998
    L Livi
    Radiotherapy Department, Florence University, Florence, Italy
    Clin Oncol (R Coll Radiol) 16:261-8. 2004
  6. ncbi Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature
    I Meattini
    Department of Radiation Oncology, University of Florence, Florence, Italy
    J Chemother 22:58-62. 2010
  7. ncbi Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas
    G Beltrami
    Department of Orthopaedic Oncology, University of Florence, Careggi, Florence, Italy
    Eur J Surg Oncol 34:811-6. 2008
  8. ncbi Postmastectomy radiotherapy in breast cancer adjuvant treatment
    L Livi
    Department of Radiation Oncology, University of Florence, Florence, Italy
    Minerva Chir 65:527-36. 2010
  9. ncbi Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index
    M Gacci
    Department of Urology, University of Florence, Florence, Italy
    Urology 66:338-43. 2005
  10. ncbi Uterine sarcoma: twenty-seven years of experience
    L Livi
    Department of Radiotherapy, University of Florence, Florence, Italy
    Int J Radiat Oncol Biol Phys 57:1366-73. 2003

Collaborators

Detail Information

Publications15

  1. ncbi Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients
    L Livi
    Department of Radiotherapy, Florence University, Florence, Italy
    Eur J Surg Oncol 31:9-12. 2005
    ..The aim of this study is to describe the University of Florence experience in evaluating clinical, pathologic and treatment factors as they are related to the outcome and loco-regional recurrence in patients with tubular breast carcinoma...
  2. ncbi Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery
    L Livi
    Radiotherapy Department, Florence University, Florence, Italy
    Clin Oncol (R Coll Radiol) 19:120-4. 2007
    ..To evaluate the incidence of locoregional recurrence (LRR) and the cosmetic results in a group of patients with breast cancer treated with a hypofractionated schedule of adjuvant radiotherapy after conservative surgery...
  3. ncbi Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines
    L Livi
    Department of Radiation Oncology, University of Florence, Florence, Italy
    J Chemother 23:158-62. 2011
    ..5%. Our experience adds to evidence supporting the activity and cardiac safety of PLD and vinorelbine in metastatic breast cancer patients previously treated with anthracycline-based adjuvant chemotherapy...
  4. ncbi Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy
    L Livi
    Department of Radiotherapy Oncology, Viale Morgagni no 85, Florence University, 50134, Florence, Italy
    Eur J Surg Oncol 33:977-81. 2007
    ....
  5. ncbi Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998
    L Livi
    Radiotherapy Department, Florence University, Florence, Italy
    Clin Oncol (R Coll Radiol) 16:261-8. 2004
    ..001). CONCLUSIONS: Prognosis is dependent on histopathological sub-type, grade and tumour stage. Adjuvant radiotherapy decreases local recurrence rate, but without significant impact on survival...
  6. ncbi Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature
    I Meattini
    Department of Radiation Oncology, University of Florence, Florence, Italy
    J Chemother 22:58-62. 2010
    ..Our experience confirmed that ibandronate may be a useful and safe co-analgesic to conventional treatments for bone pain in selected metastatic breast cancer patients...
  7. ncbi Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas
    G Beltrami
    Department of Orthopaedic Oncology, University of Florence, Careggi, Florence, Italy
    Eur J Surg Oncol 34:811-6. 2008
    ..Using our treatment algorithm for high-grade soft tissue sarcoma of the extremities, good local and systemic control can be achieved with a low complication rate...
  8. ncbi Postmastectomy radiotherapy in breast cancer adjuvant treatment
    L Livi
    Department of Radiation Oncology, University of Florence, Florence, Italy
    Minerva Chir 65:527-36. 2010
    ..We reviewed the major studies offered by literature with emphasis on the principal debated issues...
  9. ncbi Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index
    M Gacci
    Department of Urology, University of Florence, Florence, Italy
    Urology 66:338-43. 2005
    ..To validate an Italian version of the University of California-Los Angeles Prostate Cancer Index (UCLA-PCI)...
  10. ncbi Uterine sarcoma: twenty-seven years of experience
    L Livi
    Department of Radiotherapy, University of Florence, Florence, Italy
    Int J Radiat Oncol Biol Phys 57:1366-73. 2003
    ..A correlation of treatment for uterine sarcoma with outcome, prognostic importance of pathology, and clinical parameters...
  11. ncbi Use of tamoxifen in pT1a-pT1b, pN0 breast cancer
    L Livi
    Department of Radiotherapy Oncology, University of Florence, Viale Morgagni no 85, 50134 Florence, Italy
    Eur J Surg Oncol 33:271-5. 2007
    ..To evaluate if in low-risk breast cancer patients (pT1a-pT1b, pN0) tamoxifen can reduce local recurrence and improve survival...
  12. ncbi The management of elderly patients with T1-T2 breast cancer treated with or without radiotherapy
    L Livi
    Unita Di Radioterapia, University of Florence, Firenze, Italy
    Eur J Surg Oncol 31:473-8. 2005
    ..The aim of the current study is to identify a subgroup of patients with breast cancer who have a low risk of local recurrence after conservative surgery in order to avoid radiotherapy treatment...
  13. ncbi [Organ-confined prostate cancer: treatment with high doses of radioterapy (intensity modulated radiotherapy)]
    L Livi
    Departamento de Radioterapia, Universidad de Florencia, Italia
    Actas Urol Esp 31:611-6. 2007
    ..To report toxicity and local control in patients with localized prostate cancer, treated with high dose radiotherapy...
  14. ncbi Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy only
    R Santoni
    Radiation Oncology Departments, University of Firenze, Firenze, University of Rome, Tor Vergata, Roma, Italy
    BJU Int 92:47-52; discussion 52. 2003
    ..To analyse relapse patterns, toxicity and second malignancy in patients with stage I pure germ cell testicular tumours, treated in 1970-1999...
  15. ncbi Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system
    S Gelmini
    Clinical Biochemistry Unit, University of Florence, Italy
    Clin Chem Lab Med 39:385-91. 2001
    ..This assay is a promising tool for the detection and follow-up of these patients...